ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bone marrow mesenchymal stem cell-derived exosomal miR-193b-5p reduces pyroptosis after ischemic stroke by targeting AIM2

Wang, Yingju; Chen, Hongping; Fan, Xuehui; Xu, Chen; Li, Meng; Sun, Hongxue; Song, Jihe; Jia, Feihong; Wei, Wan; Jiang, Fangchao; Li, Guozhong*; Zhong, Di*哈尔滨医科大学; 1
Journal of Stroke & Cerebrovascular Diseases2023-8DOI: 10.1016/j.jstrokecerebrovasdis.2023.107235
1被引5阅读
引用收藏
分享

摘要

Background: Ischemic stroke represents a major factor causing global morbidity and death. Bone marrow mesenchymal stem cell (BMSC)-derived exosomes (Exos) have important effects on treating ischemic stroke. Here, we investigated the therapeutic mechanism by which BMSC-derived exosomal miR-193b-5p affects ischemic stroke. Methods: luciferase assay was performed to evaluate the regulatory relationship of miR-193b-5p with absent in melanoma 2 (AIM2). Additionally, an oxygen-glucose deprivation/reperfusion (OGD/R) model was constructed for the in vitro assay, while a middle cerebral artery occlusion (MCAO) model was developed for the in vivo assay. After exosome therapy, lactate dehydrogenase and MTT assays were conducted to detect cytotoxicity and cell viability, while PCR, ELISA, western blot-ting assay, and immunofluorescence staining were performed to detect changes in the levels of pyroptosis-related molecules. TTC staining and TUNEL assays were performed to assess cerebral ischemia/reperfusion (I/R) injury. Results: In the lucif-erase assay, miR-193b-5p showed direct binding to the 3MODIFIER LETTER PRIME-untranslated region of AIM2. In both in vivo and in vitro assays, the injected exosomes could access the sites of ischemic injury and could be internalized. In the in vitro assay, compared to nor-mal BMSC-Exos, miR-193b-5p-overexpressing BMSC-Exos showed greater effects on increasing cell viability and attenuating cytotoxicity; AIM2, GSDMD-N, and cleaved caspase-1 levels; and IL-1b/IL-18 generation. In the in vivo assay, com-pared to normal BMSC-Exos, miR-193b-5p-overexpressing BMSC-Exos showed greater effects on decreasing the levels of these pyroptosis-related molecules and infarct volume. Conclusion: BMSC-Exos attenuate the cerebral I/R injury in vivo and in vitro by inhibiting AIM2 pathway-mediated pyroptosis through miR-193b-5p delivery.& COPY; 2023 Elsevier Inc.

学科与关键词

关键词
BMSCsexosomescerebral ischemiareperfusion injurymiR-193b-5ppyroptosisAIM2
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Stroke & Cerebrovascular Diseases
发表日期
2023-08
卷期
第 32 卷, 第 8 期
页码
107235
DOI
10.1016/j.jstrokecerebrovasdis.2023.107235
语言
ENGLISH
成果收录
SCIE
资助标注
Heilongjiang Province Key Ramp;D Program [GA21C005, JD22C002]; National Natural Science Foun-dation of China [81873746]

作者

  • W

    Wang, Yingju (第一作者)

    1 · harbin med univ

  • C

    Chen, Hongping

    1 · harbin med univ

查看全部 12 位作者收起作者
  • F

    Fan, Xuehui

    1 · harbin med univ

  • X

    Xu, Chen

    1 · harbin med univ

  • L

    Li, Meng

    1 · harbin med univ

  • S

    Sun, Hongxue

    1 · harbin med univ

  • S

    Song, Jihe

    1 · harbin med univ

  • J

    Jia, Feihong

    1 · harbin med univ

  • W

    Wei, Wan

    1 · harbin med univ

  • J

    Jiang, Fangchao

    1 · harbin med univ

  • L

    Li, Guozhong (通讯)

    heilongjiang prov hosp · 1 · harbin med univ

  • Z

    Zhong, Di (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417